Trial Profile
Phase I trial of anti-T-Box transcription factor TBX21 gene therapy [anti-T-bet gene therapy, SB 020].
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2011
Price :
$35
*
At a glance
- Drugs Anti-T-Box transcription factor TBX21 gene therapy (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- 08 Dec 2011 New trial record